Potential antiosteoporosis effect of biodegradable magnesium implanted in STZ-induced diabetic rats

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 3, 2011, Pages 386-394

  Yang, Weili ^a   Zhang, Yu ^a   Yang, Jianhong ^a   Tan, Lili ^b   Yang, Ke ^b  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b INSTITUTE OF METAL RESEARCH   (China)

Author keywords

BMD; diabetic rat; implant; osteoporosis; pure magnesium

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BLOOD GLUCOSE; BMD; BODY WEIGHT; BONE GROWTH; CONTROL GROUPS; DIABETIC RAT; DIABETIC RATS; ENERGY DISPERSIVE X RAY SPECTROSCOPY; GLYCOSYLATED; IN-CONTROL; IN-VIVO; NONESTERIFIED FATTY ACIDS; OSTEOPOROSIS; PURE MAGNESIUM; REACTION LAYERS; RESIDUAL WEIGHT; STREPTOZOTOCIN; URIC ACIDS;

AMINO ACIDS; BLOOD; BONE; CALCIUM; FATTY ACIDS; GLUCOSE; MAGNESIUM; MAGNESIUM PRINTING PLATES; PHOSPHORUS; POTASSIUM; STRONTIUM; SULFUR; SURFACE REACTIONS; X RAY SPECTROSCOPY; ZINC;

RATS;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CHOLINESTERASE; CREATININE; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; MAGNESIUM; PHOSPHORUS; POTASSIUM; STRONTIUM; SULFUR; URIC ACID; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BIODEGRADABLE IMPLANT; BODY WEIGHT; BONE DENSITY; BONE GROWTH; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRY WEIGHT; FEMALE; FEMUR; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; OSTEOPOROSIS; RAT; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; STREPTOZOCIN DIABETES;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BLOOD GLUCOSE; BODY WEIGHT; BONE DENSITY; DIABETES MELLITUS, EXPERIMENTAL; FEMUR; IMPLANTS, EXPERIMENTAL; MAGNESIUM; MALE; MICROSCOPY, ELECTRON, SCANNING; MINERALS; ORGAN SIZE; OSTEOPOROSIS; PROSTHESIS IMPLANTATION; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ATOMIC; SURFACE PROPERTIES;

EID: 80055006679     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33201     Document Type: Article

References (42)

1. Seeman E,: Invited review: Pathogenesis of osteoporosis. J Appl Physiol 2003; 95: 2142.
2. Delmas PD,. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial. J Clin Endocrinol Metab 2002; 87: 3609-3617. (Pubitemid 34879503)
3. Zhang X, Fei Y, Zhang M, Wei D, Li M, Ding W, Yang J,. Reversal of osteoporotic changes of mineral composition in femurs of diabetic rats by insulin. Biol Trace Elem Res 2008; 121: 233-242.
4. Brown SA, Sharpless JL,. Osteoporosis: An under-appreciated complication of diabetes. Clin Diabetes 2004; 22: 10.
5. Jacobs JJ, Hallab NJ, Skipor AK, Urban RM,. Metal degradation products: A cause for concern in metal-metal bearings? Clinical Orthop Relat Res 2003; 417: 139.
6. Hallab NJ, Mikecz K, Vermes C, Skipor A, Jacobs JJ,. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation. Mol Cell Biochem 2001; 222: 127-136. (Pubitemid 32910328)
7. Hallab N, Jacobs JJ, Black J,. Hypersensitivity to metallic biomaterials: A review of leukocyte migration inhibition assays. Biomaterials 2000; 21: 1301-1314. (Pubitemid 30229855)
8. Pietak A, Mahoney P, Dias GJ, Staiger MP,. Bone-like matrix formation on magnesium and magnesium alloys. J Mater Sci: Mater Med 2008; 19: 407-415.
9. Xu L, Yu G, Zhang E, Pan F, Yang K,. In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application. J Biomed Mater Res A 2007; 83: 703-711. (Pubitemid 350086297)
10. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth C, Windhagen H,. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005; 26: 3557-3563. (Pubitemid 40038150)
11. Witte F, Fischer J, Nellesen J, Crostack HA, Kaese V, Pisch A, Beckmann F, Windhagen H,. In vitro and in vivo corrosion measurements of magnesium alloys. Biomaterials 2006; 27: 1013-1018. (Pubitemid 41566693)
12. Witte F, Ulrich H, Palm C, Willbold E,. Biodegradable magnesium scaffolds: Part II: Peri-implant bone remodeling. J Biomed Mater Res A 2007; 81: 757-765. (Pubitemid 46786908)
13. Li Z, Gu X, Lou S, Zheng Y,. The development of binary Mg-Ca alloys for use as biodegradable materials within bone. Biomaterials 2008; 29: 1329-1344.
14. Zhang S, Zhang X, Zhao C, Li J, Song Y, Xie C, Tao H, Zhang Y, He Y, Jiang Y,. Research on an Mg-Zn alloy as a degradable biomaterial. Acta Biomaterialia 2010; 6: 626-640.
15. Yang C, Yuan G, Zhang J, Tang Z, Zhang X, Dai K,. Effects of magnesium alloys extracts on adult human bone marrow-derived stromal cell viability and osteogenic differentiation. Biomed Mater 2010; 5: 045005.
16. Maguire ME, Cowan JA,. Magnesium chemistry and biochemistry. Biometals 2002; 15: 203-210. (Pubitemid 34816205)
17. Wolf FI, Cittadini A,. Chemistry and biochemistry of magnesium. Mol Aspects Med 2003; 24: 3.
18. Cowan J,. Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals 2002; 15: 225-235. (Pubitemid 34816207)
19. Musso CG,. Magnesium metabolism in health and disease. Int Urol Nephrol 2009; 41: 357-362.
20. Rude RK, Gruber HE,. Magnesium deficiency and osteoporosis: Animal and human observations. J Nutr Biochem 2004; 15: 710-716. (Pubitemid 40018113)
21. Nishimuta M, Kodama N, Morikuni E, Yoshioka YH, Takeyama H, Yamada H, Kitajima H, Suzuki K,. Balances of calcium, magnesium and phosphorus in Japanese young adults. J Nutr Sci Vitaminol (Tokyo) 2004; 50: 19-25. (Pubitemid 38405204)
22. Ayd n H, Deyneli O, Yavuz D, G zü H, Mutlu N, Kaygusuz I, Akal n S,. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Element Res 2010; 133: 136-143.
23. Kanazawa I, Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T,. A case of magnesium deficiency associated with insufficient parathyroid hormone action and severe osteoporosis. Endocr J 2007; 4: 935.
24. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J,. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. Osteoporos Int 2006; 17: 1022-1032. (Pubitemid 43864856)
25. Alexander RT, Hoenderop JG, Bindels RJ,. Molecular determinants of magnesium homeostasis: Insights from human disease. J Am Soc Nephrol 2008; 19: 1451.
26. Katsumata SI, Matsuzaki H, Uehara M, Suzuki K,. Effect of dietary magnesium supplementation on bone loss in rats fed a high phosphorus diet. Magnes Res 2005; 18: 91-96. (Pubitemid 41097388)
27. Stendig-Lindberg G, Koeller W, Bauer A, Rob PM,. Experimentally induced prolonged magnesium deficiency causes osteoporosis in the rat. Eur J Intern Med 2004; 15: 97-107. (Pubitemid 38692685)
28. Liu C, Yeh J, Aloia J,. Magnesium directly stimulates osteoblast proliferation. J Bone Miner Res 1988; 3 (Suppl 1): S104.
29. Hokura A, Matsuura H, Katsuki F, Haraguchi H,. Multielement determination of major-to-ultratrace elements in plant reference materials by ICP-AES/ICP-MS and evaluation of their enrichment factors. Anal Sci 2000; 16: 1161-1168.
30. Katsuki F, Hokura A, Iwahata D, Ikuma T, Oguri S, Haraguchi H,. Multielement determination of major-to-ultratrace elements in cherry samples by ICP-MS and ICP-AES after acid digestion. Bunseki Kagaku 1998; 47: 835-844. (Pubitemid 128406484)
31. Rude RK, Singer FR, Gruber HE,. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009; 28: 131.
32. Ilich JZ, Kerstetter JE,. Nutrition in bone health revisited: A story beyond calcium. J Am Coll Nutr 2000; 19: 715.
33. Basabe TB, Mena VMC, Faci VM, Aparicio VA, Lopez SAM, Ortega ARM,. The influence of calcium and phosphorus intake on bone mineral density in young women. Archivos latinoamericanos de nutriion 2004; 54: 203.
34. Zeni S, Weisstaub A, Di Gregorio S, Ronanre de Ferrer P, Portela ML,. Bone mass changes in vivo during the entire reproductive cycle in rats feeding different dietary calcium and calcium/phosphorus ratio content. Calcified Tissue Int 2003; 73: 594-600. (Pubitemid 37517805)
35. Sasaki S,. Calcium, magnesium, and potassium as dietary nutrients. Clin Calcium 2006; 16: 110.
36. Pointillart A, Gueguen L,. Meal-feeding and phosphorus ingestion influence calcium bioavailability evaluated by calcium balance and bone breaking strength in pigs. Bone Mineral 1993; 21: 75-81. (Pubitemid 23161160)
37. Carpenter TO, Barton CN, Park YK,. Usual dietary magnesium intake in NHANES III is associated with femoral bone mass. J Bone Miner Res 2000; 15: S292.
38. Kawaura A, Nishida Y, Takeda E,. Phosphorus intake and bone mineral density (BMD). Clin Calcium 2005; 15: 1501.
39. Hashizume M, Yamaguchi M,. Stimulatory effect of β-alanyl-L- histidinato zinc on cell proliferation is dependent on protein synthesis in osteoblastic MC3T3-E1 cells. Mol Cell Biochem 1993; 122: 59-64. (Pubitemid 23187607)
40. Marie PJ,. Strontium as therapy for osteoporosis. Curr Opin Pharmacol 2005; 5: 633-636. (Pubitemid 41614464)
41. Suchanek WL, Byrappa K, Shuk P, Riman RE, Janas VF, TenHuisen KS,. Mechanochemical-hydrothermal synthesis of calcium phosphate powders with coupled magnesium and carbonate substitution. J Solid State Chem 2004; 177: 793-799.
42. Kouisni L, Azzi M, Zertoubi M, Dalard F, Maximovitch S,. Phosphate coatings on magnesium alloy AM60 part 1: Study of the formation and the growth of zinc phosphate films. Surface Coating Technol 2004; 185: 58-67. (Pubitemid 38804459)